Skip to main content

Table 2 TKR expression on endometrial stromal tumors

From: Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors

Author

KIT (%)

PDGFRA (%)

EGFR (%)

 

ESS

UES

ESS

UES

ESS

UES

Oliva, Young et al.[79]

0/8 (0)

     

Hornick and Fletcher [80]

0/10 (0)

     

Winter, Seidman et al.[81]

0/1 (0)

     

Wang, Felix et al. [26]

3/11 (27)

2/3 (67)

    

Rushing, Shajahan et al. [27]

2/2 (100)

     

Klein and Kurman [28]

1/10 (10)

0/2 (0)

    

Leath, Straughn et al. [29]

3/3 (100)

     

Caudell, Deavers et al. [35]

0/8 (0)

1/4 (25)

    

Moinfar, Gogg-Kamerer et al. [40]

    

14/20 (70)

3/3 (100)

Salvatierra, Tarrats et al. [36]

 

1/1 (100)

    

Nakayama, Mitsuhashi et al. [76]

0/5 (0)

     

Liegl, Gully et al. [38]

0/37 (0)

 

22/37 (59)

   

Adams, Hickson et al. [39]

0/8 (0)

 

7/8 (88)

   

Mitsuhashi, Nakayama et al.[42]

 

0/1 (0)

   

1/1(100)

Zafrakas, Theodoridis et al. [31]

2/2 (100)

1/2 (50)

    

Martin, Ramesh et al. [32]

1/1 (100)

     

Trojan, Montemurro et al. [37]

0/1 (0)

 

1/1 (100)

   

Koivisto-Korander, Butzow et al. [33]

2/9 (22)

     

Cheng, Yang et al. [34]

1/12 (8)

 

4/12 (33)

   

Cossu-Rocca, Contini et al. [77]

0/23 (0)

1/5 (20)

15/23 (65)

4/5 (80)

10/23 (43)

4/5 (80)

Park, Kim et al. [78]

32/39 (82.1)

 

28/39 (71.8)

 

0/39 (0)

 

Present series (2013)

1/52 (2)

1/13 (7.7)

18/52 (34.6)

5/13 (38.5)

6/52 (11.5)

1/13 (7.7)